2
Registered trials
1
Recruiting
2
Unique sponsors
3
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
M
Musculoskeletal (ATC M)
1
V
Various (ATC V)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Supportive / diluent
1 substance
Phase III:
1
Phase II/III:
1
Phase III
1 trial-
RecruitingRigshospitalet AcademicBOTULINUM TOXIN TYPE A; SODIUM CHLORIDE
Phase II/III
1 trial-
EndedNoema Pharma AG CommercialBASIMGLURANT
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Noema Pharma AG | Commercial | 1 | Phase II/III | 0 |
| Rigshospitalet | Academic | 1 | Phase III | 1 |
New trials by year
2022
1
2023
1